RxDoctor Payments Data

Giuliana Mazza Congrove

Psychiatric/Mental Health · Waynesburg, PANPI 1548507791

Payments from drug & device makers

$919in general payments, 2019–2025

Across 52 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$444
  • Otsuka America Pharmaceutical, Inc.$132
  • E.r. Squibb & Sons, L.L.C.$88
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$60
  • Teva Pharmaceuticals USA, Inc.$49
  • Lundbeck LLC$41
  • plus $104 from 4 others

What the payments were for

  • Food & beverage$919100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$919 in reported general payments places this provider in the 60th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$36,609
Medicare patients
159
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$161,071
VraylarCariprazine Hcl15$20,762
Chlorpromazine Hcl22$7,578
Vilazodone Hcl34$4,119
Duloxetine Hcl202$3,349
Quetiapine Fumarate ErQuetiapine Fumarate13$2,078
Quetiapine Fumarate160$1,524
Olanzapine29$1,205
Trazodone Hcl141$877
Benztropine Mesylate66$851
Bupropion XlBupropion Hcl57$844
Buspirone Hcl79$840
Haloperidol21$782
Lamotrigine26$767
Aripiprazole56$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$49$161,07111 claims
AbbVieVraylar$444$20,76215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Waynesburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →